Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 2/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2858531 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL28373362 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL30341783 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL28498921 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL23091295 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL23294021 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL9307266 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL5608739 | 0.95 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL532270 | 0.95 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL4332135 | 0.95 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2699 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420685-B | Preparation method and application of functional mulberry leaf oligosaccharide | 陕西森弗天然制品有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118284620-A | IL-15 mutant fusion protein pharmaceutical composition | 山东先声生物制药有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118267451-A | Nasal cavity cleaning spray based on virus blocking agent and application thereof | 康码（上海）生物科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| US-12018430-B2 | Flame-retardant ultraviolet-resistant aramid fiber | NANTONG TEXTILE & SILK INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (CN) | 2024-06-25 | — | — | US | claimed |
| CN-118236346-A | Lung-targeted ionizable lipid nanoparticle, and preparation method and application thereof | 北京科技大学 | 2024-06-25 | — | — | CN | claimed |
| CN-118217393-A | Antibody compositions comprising specific binding to hepatitis b virus surface antigen | 北京凯因科技股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-114920667-B | Electrochemical preparation method of atta Lu Lunzhi | 湖南大学 | 2024-06-21 | — | — | CN | claimed |
| CN-118209715-A | Reagent for blood cell analysis and detection | 精匠诊断技术(江苏)有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-114557955-B | Pharmaceutical composition, preparation method and application thereof | 沈阳兴齐眼药股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-114507709-B | Protective agent for protecting free DNA in blood | 武汉承启医学检验实验室有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-102048740-A | Liposome injection prepared from ceftriaxone sodium tazobactam sodium medicinal composition | ZHIYAN HAO | 2011-05-11 | — | — | CN | claimed |
| CN-101862336-A | Irbesartan-hydrochlorothiazide drug combination liposome solid preparation | LINGGANG TAO | 2010-10-20 | — | — | CN | claimed |
| CN-101708460-A | Method for preparing starch-based adsorption carrier material | UNIV SOUTH CHINA TECH | 2010-05-19 | — | — | CN | claimed |
| CN-101637450-A | Levocarnitine liposomes injection | HAINAN YONGTIAN DRUG RES INST | 2010-02-03 | — | — | CN | claimed |
| CN-101576480-A | Method for measuring contents of cationic surface active substances by bromothymol blue spectrometry | QINGHAI INST SALT LAKES CAS (CN) | 2009-11-11 | — | — | CN | claimed |
| CN-1317035-C | Method for assembling multi-biological functional factor on micro-particle surface based on hydrazide group | UNIV TIANJIN (CN) | 2007-05-23 | — | — | CN | claimed |
| CN-1768860-A | Method for assembling multi-biological functional factor on micro-particle surface based on hydrazide group | UNIV TIANJIN (CN) | 2006-05-10 | — | — | CN | claimed |
| CN-1768859-A | Method for assembling multi-biological functional factor on micro-particle surface based on aldehyde group | UNIV TIANJIN (CN) | 2006-05-10 | — | — | CN | claimed |
| US-20040253307-A1 | Sugar-free oral transmucosal solid dosage forms and uses thereof | CEPHALON, INC. | 2004-12-16 | — | — | US | claimed |
| US-4290910-A | CONTROLLING PH, AMINE, BUFFER | TANABE SEIYAKU CO., LTD. (JP) | 1981-09-22 | — | — | US | claimed |